E Raveche - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

E Raveche

Showing results (11-20 of 16) with videos related to

Pageof 2

Sort By:

You have reached the last page of results.This site can display upto 16 results.

Cytokines, Cellular & Molecular Therapy|January 5, 2001

Antisense IL-10 abrogates the inhibitory effects of IL-10 production by transfected tumor cellsG Parker, H Fernandes, S Y Chong, et al.

Genes and Immunity|August 31, 2001

Cell cycle effects of IL-10 on malignant B-1 cellsS Yen Chong, Y C Lin, J Czarneski, et al.

Leukemia|February 1, 1997

Basic fibroblast growth factor (bFGF) upregulates the expression of bcl-2 in B cell chronic lymphocytic leukemia cell lines resulting in delaying apoptosisA König, T Menzel, S Lynen, et al.

Leukemia|January 9, 2004

Studies in NZB IL-10 knockout mice of the requirement of IL-10 for progression of B-cell lymphomaJ Czarneski, Y C Lin, S Chong, et al.

Genes and Immunity|September 2, 2011

Systemic in vivo lentiviral delivery of miR-15a/16 reduces malignancy in the NZB de novo mouse model of chronic lymphocytic leukemiaS Kasar, E Salerno, Y Yuan, et al.

Oncogene|September 3, 2013

Therapeutic implications of activation of the host gene (Dleu2) promoter for miR-15a/16-1 in chronic lymphocytic leukemiaS Kasar, C Underbayev, Y Yuan, et al.

Pageof 2

Search research articles

Showing results (11-20 of 16) with videos related to

Sort By:

Pageof 2

You have reached the last page of results.This site can display upto 16 results.

Cytokines, Cellular & Molecular Therapy|January 5, 2001

Antisense IL-10 abrogates the inhibitory effects of IL-10 production by transfected tumor cellsG Parker, H Fernandes, S Y Chong, et al.

Genes and Immunity|August 31, 2001

Cell cycle effects of IL-10 on malignant B-1 cellsS Yen Chong, Y C Lin, J Czarneski, et al.

Leukemia|February 1, 1997

Basic fibroblast growth factor (bFGF) upregulates the expression of bcl-2 in B cell chronic lymphocytic leukemia cell lines resulting in delaying apoptosisA König, T Menzel, S Lynen, et al.

Leukemia|January 9, 2004

Studies in NZB IL-10 knockout mice of the requirement of IL-10 for progression of B-cell lymphomaJ Czarneski, Y C Lin, S Chong, et al.

Genes and Immunity|September 2, 2011

Systemic in vivo lentiviral delivery of miR-15a/16 reduces malignancy in the NZB de novo mouse model of chronic lymphocytic leukemiaS Kasar, E Salerno, Y Yuan, et al.

Oncogene|September 3, 2013

Therapeutic implications of activation of the host gene (Dleu2) promoter for miR-15a/16-1 in chronic lymphocytic leukemiaS Kasar, C Underbayev, Y Yuan, et al.

Pageof 2